| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | -0.48 | 0.002 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |